Grants per year
Personal profile
Research Interests
Pathogenesis & treatment of pituitary tumors, treatment of diabetic complications
Certifications and Licenses
| Internal Medicine | |
| Endocrinology, Diabetes & Metabolism |
Training Experience
| 1972 | Residency, Hospital of the University of Pennsylvania |
| 1975 | Fellowship, Univ. of CA-Los Angeles Med. Ctr. |
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
MD, Medicine, University of Pennsylvania
… → 1969
Research interests keywords
- Diabetes
- Endocrinology
- Medicine
- Metabolism
Fingerprint
Dive into the research topics where Mark E Molitch is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 96 Finished
-
Prot#CRN00808-03: An Open Label Exploratory Study to Evaluate the Safety, Pharmacokinetics and Efficacy of CRN00808 in Patients with Acromegaly Treated with Somatostatin Analogue Based Treatment Regimens (ACROBAT EDGE)
Huang, W. (PD/PI) & Molitch, M. E. (Other)
Accelsiors CRO and Consultancy Services Ltd., Crinetics Pharmaceuticals, Inc.
8/6/19 → 8/6/22
Project: Research project
-
Prot#CRN00808-02: A Double-blind, Placebo-controlled, Randomized Withdrawal Study to Evaluate the Safety, Pharmacokinetics and Efficacy of CRN00808 in Patients with Acromegaly that are Responders to Octreotide Lar or Landreotide (ACROBAT EVOLVE)
Huang, W. (PD/PI) & Molitch, M. E. (Other)
Accelsiors CRO and Consultancy Services Ltd., Crinetics Pharmaceuticals, Inc.
8/6/19 → 8/6/22
Project: Research project
-
Prot#CLCI699C2X01B: An Open-label, Multi-Center, Roll-Over Study to Assess Long Term Safety in Patients with Endogenous Cushing’s Syndrome Who Have Completed a Prior Novartis-Sponsored Osilodrostat (LCI699) Study and are Judged by the Investigator to Bene
Huang, W. (PD/PI) & Molitch, M. E. (Other)
Novartis Pharmaceuticals Corporation
5/22/19 → 12/31/24
Project: Research project
-
Preventing Early Renal Loss Follow-up Study (PERLage)
Molitch, M. E. (PD/PI)
Joslin Diabetes Center, Inc., JDRF International
5/16/19 → 10/31/20
Project: Research project
-
Prot#: ISIS 766720-CS2: A Double Blind, Placebo-Controlled, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of ISIS 766720 (IONIS GHR-LRX, an Antisense Inhibitor of the Growth Hormone Receptor) Administered Once Every 28 Days for 16 Weeks i
Huang, W. (PD/PI) & Molitch, M. E. (Other)
Medpace Clinical Research LLC, Ionis Pharmaceuticals, Inc.
4/3/19 → 4/3/22
Project: Research project
-
Associations of Kidney Tubular Biomarkers With Incident Macroalbuminuria and Sustained Low eGFR in DCCT/EDIC
for the DCCT/EDIC Research Group, Sep 2024, In: Diabetes care. 47, 9, p. 1539-1547 9 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Author Correction: Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement (Nature Reviews Endocrinology, (2023), 19, 12, (722-740), 10.1038/s41574-023-00886-5)
Petersenn, S., Fleseriu, M., Casanueva, F. F., Giustina, A., Biermasz, N., Biller, B. M. K., Bronstein, M., Chanson, P., Fukuoka, H., Gadelha, M., Greenman, Y., Gurnell, M., Ho, K. K. Y., Honegger, J., Ioachimescu, A. G., Kaiser, U. B., Karavitaki, N., Katznelson, L., Lodish, M. & Maiter, D. & 16 others, , Jan 2024, In: Nature Reviews Endocrinology. 20, 1, p. 62 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access2 Scopus citations -
Longitudinal Trajectories of Biomarkers of Kidney Tubular Function in Type 1 Diabetes
DCCT/EDIC Research Group, May 2024, In: Kidney International Reports. 9, 5, p. 1406-1418 13 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Peak insulin drip rate associated with decreased infections post-solid organ transplant
Upadrasta, G., Affinati, A., Kumar, S., Zelada, H., Fulkerson, C., Gupta, S., Pollack, T., Andrei, A. C., Oakes, D. J., Schmidt, K., Therasse, A., Grady, K., Pham, D., Wilcox, J., Levitsky, J., Parikh, N., Ladner, D., Aleppo, G., Molitch, M. E. & Wallia, A., Jan 2024, In: Clinical Transplantation. 38, 1, e15239.Research output: Contribution to journal › Article › peer-review
Open Access -
Surveillance Imaging Strategies for Pituitary Adenomas: When, How Frequent, and When to Stop
Yuen, K. C. J., Ghalib, L., Buchfelder, M., Hughes, J., Langlois, F. & Molitch, M. E., Mar 2024, In: Endocrine Practice. 30, 3, p. 282-291 10 p.Research output: Contribution to journal › Review article › peer-review